Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
2.
Oncol Rep ; 12(1): 101-6, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15201967

RESUMO

The p16INK4A tumor suppressor gene can be inactivated by hypermethylation of the promoter region in many type of tumors including oral cancer. We recently studied the relationship of inactivation of p16INK4A and tumorigenesis in oral cancer. The aim of the present study was to describe the relationship between macroscopic changes of rat oral mucosa treated with 4-nitroquinoline 1-oxide (4NQO) and an inactivation of p16INK4A. We analyzed the relation of p16INK4A inactivation by hypermethylation of the promoter region of p16INK4A gene using polymerase chain reaction (PCR), PCR-single-strand confirmation polymorphism (PCR-SSCP), and methylation-specific-PCR (MSP). We observed that methylation of p16INK4A genes were rare in mild and moderate dysplasia, but inactivation was observed at high frequency even in severe dysplasia and SCCs in rat carcinogenesis. The expression pattern of p16INK4A protein, detected by western blotting and immunohistochemistry, were similar to the hypermethylation status of the p16INK4A promoter region. Inactivation by hypermethylation of the promoter region of p16INK4A gene was related to carcinogenesis of oral cancer.


Assuntos
4-Nitroquinolina-1-Óxido/toxicidade , Carcinoma de Células Escamosas/genética , Inibidor p16 de Quinase Dependente de Ciclina/genética , Metilação de DNA , Neoplasias da Língua/genética , Animais , Sequência de Bases , Carcinógenos , Carcinoma de Células Escamosas/induzido quimicamente , Carcinoma de Células Escamosas/patologia , Primers do DNA , DNA de Neoplasias/genética , Éxons/genética , Perda de Heterozigosidade , Mucosa Bucal/efeitos dos fármacos , Mucosa Bucal/patologia , Ratos , Neoplasias da Língua/induzido quimicamente , Neoplasias da Língua/patologia
3.
Cancer Sci ; 94(10): 894-900, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-14556663

RESUMO

DNA-PK is a nuclear protein with serine/threonine kinase activity and forms a complex consisting of the DNA-PKcs and a heterodimer of Ku70 and Ku80 proteins. Recent laboratory experiments have demonstrated that the DNA-PK complex formation is one of the major pathways by which mammalian cells respond to DNA double-strand breaks induced by ionizing radiation. In this study, we evaluated the relationship between expression levels of DNA-PKcs, Ku70 and Ku80 proteins and radiation sensitivity in oral squamous cell carcinoma (OSCC) cell lines and in OSCC patients treated with preoperative radiation therapy. The OSCC cell lines greatly differed in their response to irradiation, as assessed by a standard colony formation assay. However, the expression levels of the DNA-PK complex proteins were all similar, and there was no association between the magnitude of their expression and the tumor radiation sensitivity. Expression of DNA-PK complex proteins increased after radiation treatment, and the increased values correlated with the tumor radiation resistance. Expression of DNA-PKcs and Ku70 after irradiation was increased in the surviving cells of OSCC tissues irradiated preoperatively. These results suggest that up-regulation of DNA-PK complex protein, especially DNA-PKcs, after radiation treatment correlates to radiation resistance. DNA-PKcs might be a molecular target for a novel radiation sensitization therapy of OSCC.


Assuntos
Carcinoma de Células Escamosas/enzimologia , Carcinoma de Células Escamosas/radioterapia , Neoplasias Bucais/enzimologia , Neoplasias Bucais/radioterapia , Proteínas Serina-Treonina Quinases/metabolismo , Tolerância a Radiação , Regulação para Cima , Adulto , Idoso , Idoso de 80 Anos ou mais , Antígenos Nucleares/metabolismo , Biópsia , Carcinoma de Células Escamosas/metabolismo , Carcinoma de Células Escamosas/patologia , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos da radiação , Proteína Quinase Ativada por DNA , Proteínas de Ligação a DNA/metabolismo , Feminino , Regulação Neoplásica da Expressão Gênica/efeitos da radiação , Humanos , Autoantígeno Ku , Masculino , Pessoa de Meia-Idade , Neoplasias Bucais/metabolismo , Neoplasias Bucais/patologia , Proteínas Nucleares , Regulação para Cima/efeitos da radiação
4.
Oncology ; 63(1): 92-8, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12187077

RESUMO

Epidermal growth factor receptor (EGFR) regulates the growth and progression of human oral squamous cell carcinoma (SCC). Recently, the link between EGFR signaling and the cell cycle has been identified. Some reports have described that EGFR-blocking monoclonal antibody 225 (mAb225) induced G1 arrest and inhibited the growth of various cancer cells. The purpose of this study was to evaluate the effect of mAb225 on human oral SCC cell lines. Exposure to mAb225 in culture inhibited the growth of oral SCC cell lines in an EGFR number-independent manner, with the percent inhibition ranging from 13.8 to 76.6%. Flow-cytometric analysis demonstrated that treatment with mAb225 induced cell accumulation in G1 phase, accompanied by a decrease in the percentage of cells in the S phase. Apoptosis was not seen in this study. G1 arrest was accompanied by a decrease in CDK2-, CDK4-, and CDK6-associated histone H1 kinase activities, and an increase in the expression levels of cell cycle inhibitors p27(KIP1) and p15(INK4B). These results suggested that the antiproliferative effect of EGFR blockade by mAb225 in oral SCC may be mediated by p27(KIP1) and p15(INK4B).


Assuntos
Anticorpos Monoclonais/farmacologia , Antineoplásicos/farmacologia , Quinases relacionadas a CDC2 e CDC28 , Carcinoma de Células Escamosas/metabolismo , Proteínas de Ciclo Celular/metabolismo , Inibidor p16 de Quinase Dependente de Ciclina/metabolismo , Fase G1/efeitos dos fármacos , Neoplasias Bucais/metabolismo , Proteínas Supressoras de Tumor/metabolismo , Anticorpos Monoclonais Humanizados , Carcinoma de Células Escamosas/patologia , Divisão Celular/efeitos dos fármacos , Cetuximab , Quinase 2 Dependente de Ciclina , Inibidor de Quinase Dependente de Ciclina p15 , Inibidor de Quinase Dependente de Ciclina p27 , Quinases Ciclina-Dependentes/metabolismo , Receptores ErbB/antagonistas & inibidores , Receptores ErbB/imunologia , Citometria de Fluxo , Humanos , Neoplasias Bucais/patologia , Proteínas Serina-Treonina Quinases/metabolismo , Células Tumorais Cultivadas , Regulação para Cima
5.
Oral Oncol ; 38(7): 664-9, 2002 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12167418

RESUMO

Here, we report the establishment of a stably transfected cell line which expresses high levels of green fluorescent protein (GFP), thus permitting the detection and visualization of developing tumors and lymph node metastases after injection into nude mice. Cells of the human oral squamous carcinoma cell line (SAS-L1) were transfected with an expression vector containing a cDNA encoding humanized GFP and the neomycin resistance gene. A clone with stable high-level expression of GFP was selected in vitro using G418. To study metastasis formation, GFP-expressing cells were injected orthotopically into the tongue of nude mice. The resultant tumor growth in the tongue and micrometastases in the lymph nodes could be visualized by GFP fluorescence. Therefore a useful model has been developed for the study of oral cancer, firstly to understand the metastatic process and secondly for the evaluation of potential treatments.


Assuntos
Carcinoma de Células Escamosas/secundário , Indicadores e Reagentes , Proteínas Luminescentes , Neoplasias Bucais/patologia , Animais , Modelos Animais de Doenças , Proteínas de Fluorescência Verde , Metástase Linfática/diagnóstico , Camundongos , Camundongos Nus , Microscopia de Fluorescência , Neoplasias Bucais/química , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA